Structure of the calcium channel antagonist, nimodipine
- 15 November 1989
- journal article
- research article
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section C Crystal Structure Communications
- Vol. 45 (11), 1748-1751
- https://doi.org/10.1107/s010827018900329x
Abstract
Isopropyl 2-methoxyethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate, C21H26N2O7, Mr = 418.cntdot.45, orthorhomic, P212121, a = 12.cntdot.5897 (6), b = 14.cntdot.6410 (9), c = 11.cntdot.636 (1) .ANG., V = 2144.cntdot.8 (2) .ANG.3, Z = 4, Dm = 1.cntdot.29, Dx = 1.cntdot.30 g cm-3, .lambda.(Cu K.alpha.) = 1.cntdot.54178 .ANG., .mu. = 7.cntdot.77 cm-1, F(000) = 888, T = 298 K, R = 0.cntdot.047 for 1629 observed reflections. The structure of the title compound is similar to that of related analogs, the nitrophenyl ring being roughly normal to the dihydropyridine ring, which is in a boat conformation (N1 is 10.cntdot.75.degree. out of the C2.sbd.C3.sbd.C5.sbd.C6 plane; C4 is 19.cntdot.55.degree. out of plane). The 3,5 substituents are in an extended conformation, away from the 2,6 methyl groups. The nitro group is distal to N1. Structure/activity relationships of 1,4-dihydropyridines are discussed in light of this structure.This publication has 6 references indexed in Scilit:
- CONFORMATIONAL FEATURES OF CALCIUM-CHANNEL AGONIST AND ANTAGONIST ANALOGS OF NIFEDIPINE1985
- KINETICS OF BINDING OF MEMBRANE-ACTIVE DRUGS TO RECEPTOR-SITES - DIFFUSION-LIMITED RATES FOR A MEMBRANE BILAYER APPROACH OF 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL ANTAGONISTS TO THEIR ACTIVE-SITE1985
- Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.Proceedings of the National Academy of Sciences, 1984
- CHARACTERIZATION OF BINDING OF THE CA++ CHANNEL ANTAGONIST, [H-3]-LABELED NITRENDIPINE, TO GUINEA-PIG ILEAL SMOOTH-MUSCLE1983
- Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 3-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridineJournal of Medicinal Chemistry, 1982
- Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridineJournal of Medicinal Chemistry, 1980